Allarity Therapeutics Inc NASDAQ:ALLR:
ALLARITY THERAPEUTICS ANNOUNCES THE GRANT OF ESSENTIAL U.S. PATENT FOR ITS STENOPARIB DRP® COMPANION DIAGNOSTIC
ALLARITY THERAPEUTICS - GRANTED PATENT TERM EXTENDS INTO APRIL 2042
ALLARITY THERAPEUTICS - HAS PATENT PROTECTION FOR STENOPARIB DRP IN EUROPE AND AUSTRALIA INTO 2039